Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarshalls Regulatory News (MSLH)

Share Price Information for Marshalls (MSLH)

Share Price is delayed by 15 minutes
Get Live Data
130.90    -0.70 (-0.53%)
Bid:
131.30
Ask:
131.60
Spread: 0.30 (0.228%)
Market Cap: £331.03m
MSLH Live PriceLast checked at - London Stock Exchange

Intraday Marshalls Share Chart

Board Appointment

29 Apr 2021 07:00

RNS Number : 9923W
Marshalls PLC
29 April 2021
 

29 April 2021

 

Marshalls plc

(the "Company" or "Marshalls")

 

Board Appointment

 

Justin Lockwood appointed as CFO

 

Marshalls plc, the specialist landscape products group, is pleased to announce the appointment of Justin Lockwood to the Board as Chief Financial Officer.

 

Justin is currently the Chief Financial Officer of International Personal Finance plc. He joined them in 2010 and held a number of senior finance roles prior to his appointment as CFO in 2017. Justin brings extensive experience of all aspects of financial management in large publicly listed companies.

 

Prior to International Personal Finance plc, Justin worked for Associated British Ports for four years in a senior finance role. His first role in industry was with Marshalls, between 2002 and 2006, where he worked in a variety of business unit and head office roles, including as finance director of Marshalls Clay Products before its disposal to Hanson plc. Justin is a chartered accountant, having qualified with PwC where he spent the first 10 years of his career.

 

Justin succeeds Jack Clarke who stepped down from the Board, and as Group Finance Director, on 31 March 2021. His appointment will take effect at a date to be agreed once his departure date from International Personal Finance plc has been finalised.

 

Martyn Coffey, CEO of Marshalls commented:

 

"We're delighted that Justin is joining the business. His rich, cross-sector experience, which includes time with Marshalls earlier in his career, will be an asset to the Board and help us capitalise on future growth opportunities and deliver our strategic objectives. In Justin, we're confident we've found an outstanding successor to Jack Clarke, who made a significant contribution to the sustained growth of Marshalls during his time with us."

 

Justin Lockwood commented:

 

"Marshalls is an exceptional business with strong heritage and a clear strategic vision. I'm delighted to be joining and look forward to working with Martyn, the Board and all of Marshalls' very dedicated colleagues"

 

There are no disclosures required pursuant to Listing Rule 9.6.13.

 

- Ends -

 

The information communicated in this announcement is inside information.

 

Enquiries:

 

Martyn Coffey, Chief Executive

Marshalls plc

+44 (0)1422 314777

Shiv Sibal, Company Secretary

Marshalls plc

+44 (0)1422 314767

Andrew Jaques

MHP Communications

+44 (0)20 3128 8540

Charlie Barker

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUWVARAWUSUUR
Date   Source Headline
2nd Jun 20267:00 amRNSHolding(s) in Company
29th May 202612:17 pmRNSHolding(s) in Company
22nd May 20264:01 pmRNSDirector/PDMR Shareholding
22nd May 20263:58 pmRNSDirector/PDMR Shareholding
15th May 202611:04 amRNSDirector/PDMR Shareholding
15th May 202611:03 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
13th May 20263:08 pmRNSResult of AGM
13th May 20267:00 amRNSAGM Trading Update
15th Apr 202612:17 pmRNSDirector/PDMR Shareholding
15th Apr 202612:15 pmRNSDirector/PDMR Shareholding
17th Mar 20263:01 pmRNSDirector/PDMR Shareholding
17th Mar 20262:59 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSFinal Results
16th Mar 20267:00 amRNSFinal Results
11th Mar 20264:27 pmRNSDirector/PDMR Shareholding
11th Mar 20264:27 pmRNSDirector/PDMR Shareholding
11th Mar 20264:18 pmRNSDirector/PDMR Shareholding
11th Mar 20264:18 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNS-RNotice of Engage Investor Presentation
13th Feb 20263:21 pmRNSDirector/PDMR Shareholding
13th Feb 20263:04 pmRNSDirector/PDMR Shareholding
13th Feb 20263:04 pmRNSDirector/PDMR Shareholding
19th Jan 20267:01 amRNSTrading Statement
19th Jan 20267:00 amRNSDirectorate change
9th Jan 202612:40 pmRNSDirector/PDMR Shareholding
9th Jan 202612:38 pmRNSDirector/PDMR Shareholding
6th Jan 20269:36 amRNSNotice of Trading Update
9th Dec 20253:21 pmRNSDirector/PDMR Shareholding
27th Nov 20257:00 amRNSBoard changes
12th Nov 20257:00 amRNSTrading Update
10th Nov 202510:30 amRNSDirector/PDMR Shareholding
10th Nov 202510:29 amRNSDirector/PDMR Shareholding
10th Nov 202510:27 amRNSDirector/PDMR Shareholding
30th Oct 20259:01 amRNSNotice of Trading Update
9th Oct 202512:45 pmRNSDirector/PDMR Shareholding
9th Oct 202512:44 pmRNSDirector/PDMR Shareholding
9th Oct 202512:42 pmRNSDirector/PDMR Shareholding
10th Sep 202512:06 pmRNSDirector/PDMR Shareholding
10th Sep 202512:05 pmRNSDirector/PDMR Shareholding
10th Sep 202512:04 pmRNSDirector/PDMR Shareholding
12th Aug 20259:28 amRNSDirector/PDMR Shareholding
11th Aug 20251:57 pmRNSDirector/PDMR Shareholding
11th Aug 20257:00 amRNSHalf year results
7th Aug 20257:00 amRNSDirectorate Change
28th Jul 202512:26 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.